Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X
Signal Transduct Target Ther. 2025; 10(1):31.
PMID: 39894843
PMC: 11788444.
DOI: 10.1038/s41392-024-02071-0.
Yang Y, Xu Z, Li C, Wang C, Zhao H, Xu Z
Neurol Sci. 2024; .
PMID: 39724321
DOI: 10.1007/s10072-024-07956-0.
Kim J, Kim A, Kim J, Gil Y, Kim Y, Shin D
Neurochem Res. 2024; 50(1):37.
PMID: 39601947
DOI: 10.1007/s11064-024-04278-7.
Zhou Z, Yi L, Wang D, Lim T, Tan E
Transl Neurodegener. 2023; 12(1):44.
PMID: 37718439
PMC: 10506345.
DOI: 10.1186/s40035-023-00378-6.
Lin Q, Shahid S, Hone-Blanchet A, Huang S, Wu J, Bisht A
Hum Brain Mapp. 2023; 44(8):3072-3083.
PMID: 36929676
PMC: 10171513.
DOI: 10.1002/hbm.26263.
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis.
Krajnc N, Bsteh G, Kasprian G, Zrzavy T, Kornek B, Berger T
Front Neurol. 2022; 13:928582.
PMID: 35865643
PMC: 9295598.
DOI: 10.3389/fneur.2022.928582.
Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging.
Khattar N, Triebswetter C, Kiely M, Ferrucci L, Resnick S, Spencer R
Neuroimage. 2021; 239:118267.
PMID: 34139358
PMC: 8370037.
DOI: 10.1016/j.neuroimage.2021.118267.
Alterations and Associations Between Magnetic Susceptibility of the Basal Ganglia and Diffusion Properties in Alzheimer's Disease.
Liu X, Du L, Zhang B, Zhao Z, Gao W, Liu B
Front Neurosci. 2021; 15:616163.
PMID: 33664645
PMC: 7921325.
DOI: 10.3389/fnins.2021.616163.
Inflaming the Brain with Iron.
Urrutia P, Borquez D, Nunez M
Antioxidants (Basel). 2021; 10(1).
PMID: 33419006
PMC: 7825317.
DOI: 10.3390/antiox10010061.
Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2 mapping.
Cheng Q, Huang J, Liang J, Ma M, Zhao Q, Lei X
Exp Ther Med. 2020; 19(6):3778-3786.
PMID: 32346442
PMC: 7185157.
DOI: 10.3892/etm.2020.8645.
Longitudinal Development of Brain Iron Is Linked to Cognition in Youth.
Larsen B, Bourque J, Moore T, Adebimpe A, Calkins M, Elliott M
J Neurosci. 2020; 40(9):1810-1818.
PMID: 31988059
PMC: 7046454.
DOI: 10.1523/JNEUROSCI.2434-19.2020.
Visualization of Nigrosome 1 from the Viewpoint of Anatomic Structure.
Arai N, Kan H, Ogawa M, Uchida Y, Takizawa M, Omori K
AJNR Am J Neuroradiol. 2019; 41(1):86-91.
PMID: 31806600
PMC: 6975307.
DOI: 10.3174/ajnr.A6338.
Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
Shahmaei V, Faeghi F, Mohammdbeigi A, Hashemi H, Ashrafi F
Eur J Radiol Open. 2019; 6:169-174.
PMID: 31065578
PMC: 6495059.
DOI: 10.1016/j.ejro.2019.04.005.
The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.
Kaindlstorfer C, Jellinger K, Eschlbock S, Stefanova N, Weiss G, Wenning G
J Alzheimers Dis. 2018; 61(4):1253-1273.
PMID: 29376857
PMC: 5798525.
DOI: 10.3233/JAD-170601.
Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients.
Fernandez B, Ferrer I, Gil F, Hilfiker S
Toxicol Rep. 2017; 4:188-193.
PMID: 28529891
PMC: 5436624.
DOI: 10.1016/j.toxrep.2017.03.005.
Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements.
Wang J, Zhuang Q, Zhu L, Zhu H, Li T, Li R
Sci Rep. 2016; 6:36669.
PMID: 27827408
PMC: 5101491.
DOI: 10.1038/srep36669.
Multimodal 7T Imaging of Thalamic Nuclei for Preclinical Deep Brain Stimulation Applications.
Xiao Y, Zitella L, Duchin Y, Teplitzky B, Kastl D, Adriany G
Front Neurosci. 2016; 10:264.
PMID: 27375422
PMC: 4901062.
DOI: 10.3389/fnins.2016.00264.
Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?.
Hopes L, Grolez G, Moreau C, Lopes R, Ryckewaert G, Carriere N
PLoS One. 2016; 11(4):e0147947.
PMID: 27035571
PMC: 4818028.
DOI: 10.1371/journal.pone.0147947.
Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X, Xuan M, Gu Q, Huang P, Liu C, Wang N
NMR Biomed. 2016; 30(4).
PMID: 26853890
PMC: 4977211.
DOI: 10.1002/nbm.3489.
Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N, Ling H, Ding B, Huang J, Zhang Y, Zhang Z
Hum Brain Mapp. 2015; 36(11):4407-20.
PMID: 26249218
PMC: 6869507.
DOI: 10.1002/hbm.22928.